How Roche’s new deal with LumiraDx will transform Point of Care testing forever
Roche Holding AG has finalised its acquisition of LumiraDx’s innovative Point of Care technology, a strategic move aimed at enhancing its diagnostic portfolio and expanding ... Read More
Roche to acquire LumiraDx’s Point of Care technology for $350m to expand diagnostics reach
Roche has announced a definitive agreement to acquire select parts of LumiraDx Group related to its innovative Point of Care technology, a deal totaling $350 ... Read More
Roche, Lilly team up to develop EAPP blood test for Alzheimer’s disease
Roche is teaming up with Eli Lilly and Company (Lilly) to support the development of its Elecsys Amyloid Plasma Panel (EAPP) blood test which has ... Read More